BIRDX | DRLAX | BIRDX / DRLAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 18 years | - |
Gain YTD | 8.883 | 10.332 | 86% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000000 | 1000 | 200,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.98B | 325M | 917% |
Annual Yield % from dividends | 3.02 | 2.42 | 125% |
Returns for 1 year | 19.46 | 20.38 | 95% |
Returns for 3 years | -7.46 | -14.86 | 50% |
Returns for 5 years | 7.76 | -2.09 | -371% |
Returns for 10 years | N/A | 15.91 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSFEX | 15.48 | 0.02 | +0.13% |
Morgan Stanley Inst Next Gen Em Mkts C | |||
GEMEX | 24.40 | N/A | N/A |
GMO Emerging Markets I | |||
SBMLX | 22.92 | -0.05 | -0.22% |
ClearBridge Mid Cap C | |||
CSCIX | 15.06 | -0.05 | -0.33% |
Cohen & Steers Real Estate Securities C | |||
BRLGX | 34.73 | -0.22 | -0.63% |
American Beacon Man Lg Cp Growth R5 |